Anne Arundel Medical Center in Maryland reduced opioid prescribing over a 16-month period by implementing interventions to educate prescribers, patients and the public about opioid risks and safety and promote clinician accountability, according to a study published Friday by JAMA Network Open. Monthly morphine milligram equivalents per encounter and MME per opioid prescription fell by 58 percent and 34 percent, respectively, compared with the average for the baseline period, while the opioid prescription rate fell by 38 percent. “Our data demonstrate that it is possible, through a coordinated, multilevel campaign, to reduce opioid overprescribing without worsening overall patient satisfaction,” the authors said. The AHA offers a toolkit to help hospitals and health systems work with their patients, clinicians and communities to tackle the opioid epidemic.

Related News Articles

Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…